246 related articles for article (PubMed ID: 37428824)
1. Knowledge Gaps in Generating Cell-Based Drug Delivery Systems and a Possible Meeting with Artificial Intelligence.
Mozafari N; Mozafari N; Dehshahri A; Azadi A
Mol Pharm; 2023 Aug; 20(8):3757-3778. PubMed ID: 37428824
[TBL] [Abstract][Full Text] [Related]
2. Predicting Nanoparticle Delivery to Tumors Using Machine Learning and Artificial Intelligence Approaches.
Lin Z; Chou WC; Cheng YH; He C; Monteiro-Riviere NA; Riviere JE
Int J Nanomedicine; 2022; 17():1365-1379. PubMed ID: 35360005
[TBL] [Abstract][Full Text] [Related]
3. Artificial intelligence to bring nanomedicine to life.
Serov N; Vinogradov V
Adv Drug Deliv Rev; 2022 May; 184():114194. PubMed ID: 35283223
[TBL] [Abstract][Full Text] [Related]
4. Artificial intelligence and machine learning disciplines with the potential to improve the nanotoxicology and nanomedicine fields: a comprehensive review.
Singh AV; Varma M; Laux P; Choudhary S; Datusalia AK; Gupta N; Luch A; Gandhi A; Kulkarni P; Nath B
Arch Toxicol; 2023 Apr; 97(4):963-979. PubMed ID: 36878992
[TBL] [Abstract][Full Text] [Related]
5. Artificial Intelligence and Machine Learning in Computational Nanotoxicology: Unlocking and Empowering Nanomedicine.
Singh AV; Ansari MHD; Rosenkranz D; Maharjan RS; Kriegel FL; Gandhi K; Kanase A; Singh R; Laux P; Luch A
Adv Healthc Mater; 2020 Sep; 9(17):e1901862. PubMed ID: 32627972
[TBL] [Abstract][Full Text] [Related]
6. Artificial intelligence aids in development of nanomedicines for cancer management.
Tan P; Chen X; Zhang H; Wei Q; Luo K
Semin Cancer Biol; 2023 Feb; 89():61-75. PubMed ID: 36682438
[TBL] [Abstract][Full Text] [Related]
7. Integrating Artificial Intelligence and Nanotechnology for Precision Cancer Medicine.
Adir O; Poley M; Chen G; Froim S; Krinsky N; Shklover J; Shainsky-Roitman J; Lammers T; Schroeder A
Adv Mater; 2020 Apr; 32(13):e1901989. PubMed ID: 31286573
[TBL] [Abstract][Full Text] [Related]
8. Current understanding of biological interactions and processing of DNA origami nanostructures: Role of machine learning and implications in drug delivery.
Singh M; Sharma D; Garg M; Kumar A; Baliyan A; Rani R; Kumar V
Biotechnol Adv; 2022 Dec; 61():108052. PubMed ID: 36307050
[TBL] [Abstract][Full Text] [Related]
9. Re-envisioning the design of nanomedicines: harnessing automation and artificial intelligence.
Zaslavsky J; Bannigan P; Allen C
Expert Opin Drug Deliv; 2023 Feb; 20(2):241-257. PubMed ID: 36644850
[TBL] [Abstract][Full Text] [Related]
10. Artificial intelligence-powered microfluidics for nanomedicine and materials synthesis.
Liu L; Bi M; Wang Y; Liu J; Jiang X; Xu Z; Zhang X
Nanoscale; 2021 Dec; 13(46):19352-19366. PubMed ID: 34812823
[TBL] [Abstract][Full Text] [Related]
11. Artificial intelligence and machine learning in nanomedicine. What do we expect for 2030?
Figueiró Longo JP; Narcizo de Souza PE; Morais PC
Nanomedicine (Lond); 2023 Jul; 18(16):1041-1043. PubMed ID: 37578157
[No Abstract] [Full Text] [Related]
12. Tailoring the Inherent Properties of Biobased Nanoparticles for Nanomedicine.
Zahid AA; Chakraborty A; Luo W; Coyle A; Paul A
ACS Biomater Sci Eng; 2023 Jul; 9(7):3972-3986. PubMed ID: 37378614
[TBL] [Abstract][Full Text] [Related]
13. A concise review: the synergy between artificial intelligence and biomedical nanomaterials that empowers nanomedicine.
Hayat H; Nukala A; Nyamira A; Fan J; Wang P
Biomed Mater; 2021 Aug; 16(5):. PubMed ID: 34280907
[TBL] [Abstract][Full Text] [Related]
14. Artificial intelligence in spine care: current applications and future utility.
Hornung AL; Hornung CM; Mallow GM; Barajas JN; Rush A; Sayari AJ; Galbusera F; Wilke HJ; Colman M; Phillips FM; An HS; Samartzis D
Eur Spine J; 2022 Aug; 31(8):2057-2081. PubMed ID: 35347425
[TBL] [Abstract][Full Text] [Related]
15. Artificial intelligence and machine learning in precision medicine: A paradigm shift in big data analysis.
Sahu M; Gupta R; Ambasta RK; Kumar P
Prog Mol Biol Transl Sci; 2022; 190(1):57-100. PubMed ID: 36008002
[TBL] [Abstract][Full Text] [Related]
16. Artificial intelligence and machine learning for protein toxicity prediction using proteomics data.
Vishnoi S; Matre H; Garg P; Pandey SK
Chem Biol Drug Des; 2020 Sep; 96(3):902-920. PubMed ID: 33058462
[TBL] [Abstract][Full Text] [Related]
17. Machine Learning and Artificial Intelligence: A Paradigm Shift in Big Data-Driven Drug Design and Discovery.
Pasrija P; Jha P; Upadhyaya P; Khan MS; Chopra M
Curr Top Med Chem; 2022; 22(20):1692-1727. PubMed ID: 35786336
[TBL] [Abstract][Full Text] [Related]
18. Nanomedicine Ex Machina: Between Model-Informed Development and Artificial Intelligence.
Villa Nova M; Lin TP; Shanehsazzadeh S; Jain K; Ng SCY; Wacker R; Chichakly K; Wacker MG
Front Digit Health; 2022; 4():799341. PubMed ID: 35252958
[TBL] [Abstract][Full Text] [Related]
19. Towards machine learning for hydrogel drug delivery systems.
Owh C; Ho D; Loh XJ; Xue K
Trends Biotechnol; 2023 Apr; 41(4):476-479. PubMed ID: 36376126
[TBL] [Abstract][Full Text] [Related]
20. Merging data curation and machine learning to improve nanomedicines.
Chen C; Yaari Z; Apfelbaum E; Grodzinski P; Shamay Y; Heller DA
Adv Drug Deliv Rev; 2022 Apr; 183():114172. PubMed ID: 35189266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
